General Gastro News Articles

Gastro

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Xu MZ et al. - YAP is an independent prognostic marker for overall survival and disease-free survival times of HCC patients and clinicopathologically associated with tumor differentiation and serum AFP level. It is a potential therapeutic target for this aggressive malignancy.

Related Articles

Epidermal Growth Factor-Containing Fibulin-Like Extracellular Matrix Protein 1, EFEMP1, a Novel Tumor-Suppressor Gene Detected in Hepatocellular Carcinoma Using Double Combination Array Analysis
Annals of Surgical Oncology, 11/11/09    Relevance Score: 69%

Percutaneous Radiofrequency Ablation of Hepatocellular Carcinoma in 14 Patients Undergoing Regular Hemodialysis for End-Stage Renal Disease
American Journal of Roentgenology, 10/09/09    Relevance Score: 69%

Inhibitory effects of genistein on metastasis of human hepatocellular carcinoma
World Journal of Gastroenterology, 10/27/09    Relevance Score: 68%

Cryotherapy for hepatocellular carcinoma
Cochrane Reviews, 10/09/09    Relevance Score: 68%

MicroRNA expression, survival, and response to Interferon in liver cancer
New England Journal of Medicine, 10/08/09    Relevance Score: 68%

Today in Hepatology...keeping you current

The Influence of Induction Therapy on Graft and Patient Survival in Patients with and without Hepatitis C after Liver Transplantation
American Journal of Transplantation, 12/08/09

Hypothermic Machine Preservation in Human Liver Transplantation: The First Clinical Series
American Journal of Transplantation, 12/08/09

Inhibition of hepatoma 22 tumor by Liquiritigenin
Phytotherapy Research, 12/08/09